Large-effect genetic variants in susceptibility to invasive
pneumococcal disease
Applications are invited for a MRC/NDM-funded DPhil Studentship in Clinical
Medicine, based at the Wellcome Trust Centre for Human Genetics, University of
Oxford, UK.
The aim of the studentship project is to utilise DNA sequencing technology to
identify novel, large-effect genetic susceptibility variants for invasive
pneumococcal disease in African and European populations.
The studentship is specifically intended to train a Kenyan national with the
long-term aim of enhancing research capacity in Kenya.
Full details of the project can be found at www.kemri-wellcome.org
Training opportunities
The DPhil studentship will be based in Professor Adrian Hill’s laboratory at
the Wellcome Trust Centre for Human Genetics in Oxford, UK (www.well.ox.ac.uk/hill-2).
The Centre is an internationally recognised centre of excellence for genomics
research with state-of-the-art facilities.
The DPhil is funded by the Medical Research Council UK and the Nuffield
Department of Clinical Medicine, University of Oxford.
Applicants should have, or expect to have, a degree in molecular biology, human
genetics, immunogenetics or a closely related field, with a minimum of a 2.1
class.
Applicants are also required to have a suitable English language qualification,
as detailed on the website at www.ox.ac.uk/admissions/postgraduate_courses/apply/internat_students.html.
Applications should be made through the online portal at https://apply.embark.com/grad/Oxford/15/
listing the title ‘Large-effect genetic variants in susceptibility to invasive
pneumococcal disease’ and reference code ‘Pneumogene’.
The closing date for applications is Friday 23 December 2011.